Silent cerebral infarcts in sickle cell anemia: A risk factor analysis

Pediatrics

Volumn 103, Issue 3, 1999, Pages 640-645

  Kinney, Thomas R ^a   Sleeper, Lynn A ^b   Wang, Winfred C ^c   Zimmerman, Robert A ^d   Pegelow, Charles H ^e   Ohene Frempong, Kwaku ^d   Wethers, Doris L ^f   Bello, Jacqueline A ^g   Vichinsky, Elliott P ^h   Moser, Franklin G ⁱ   Gallagher, Dianne M ^b   DeBaun, Michael R ^l   Platt, Orah S ^j   Miller, Scott T ^k  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h CHILDREN S HOSPITAL OAKLAND   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k SUNY DOWNSTATE MEDICAL CENTER   (United States)

^l NONE

more..

Author keywords

Cerebral infarction; Sickle cell disease

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MONITORING; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; SICKLE CELL ANEMIA; THROMBOCYTE COUNT;

ADOLESCENT; ANEMIA, SICKLE CELL; CEREBRAL INFARCTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 0032989606     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.3.640     Document Type: Article

References (26)

1. Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Ann Intern Med. 1972;76:643-652
2. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM, and the Cooperative Study of Sickle Cell Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;1:288-294
3. Moser FG, Miller ST, Bello JA, et al. The spectrum of central nervous system abnormalities in sickle cell disease as defined by magnetic resonance imaging: a report from the Cooperative Study of Sickle Cell Disease. AJNR. 1996;17:965-972
4. Armstrong FD, Thompson RJ, Wang W, Zimmerman R, Pegelow CH, Miller S, Moser F, Bello J, Hurtig A, Vass K, for the Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics. 1996;97:864-870
5. Gaston M, Rosse WF. The Cooperative Study of Sickle Cell Disease: review of design and objectives. Am J Pediatr Hematol Oncol. 1982;4: 197-201
6. Gaston M, Smith J, Gallagher D, et al. Recruitment in the Cooperative Study of Sickle Cell Disease. Control Clin Trials. 1987;8(suppl):131S-140S
7. Farber M, Koshy M, Kinney TR, and the Cooperative Study of Sickle Cell Disease. Cooperative Study of Sickle Cell Disease: demographics and socioeconomic characteristics of patients and families with sickle cell disease. J Chron Dis. 1985;38:495-505
8. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal haemoglobin. Nature. 1959;184:1877-1878
9. Dozy AM, Kan YW, Embury SH, et al. α-Globin gene organization in blacks precludes the severe form of α-thalassemia. Nature. 1979;280: 605-607
10. Embury SH Miller JA, Dozy Am, et al. Two different molecular organizations account for the single α-globin gene in the α-thalassemia-2 genotype. J Clin Invest. 1980;66:1319-1325
11. Antonarakis SE, Kazarian HH Jr, Orkin SH. DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet. 1985;69:1-14
12. Pearson HA, Gallagher D, Chilcote R, Sullivan E, Wilmas J, Espeland M, Ritchey AK, and the Cooperative Study of Sickle Cell Disease. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics. 1985;76:392-397
13. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11-16
14. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;30:1639-1644
15. Leiken SL, Gallagher D, Kinney TR. et al. Mortality in children and adolescents with sickle cell disease. Pediatrics. 1989;84:500-508
16. Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo GJ. Neuropsychological test findings in subjects with leukoaraiosis. Arch Neurol 1989;46:40-44
17. Powars DR, Weiss JN, Chan LS, et al. Is there a threshold of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood. 1984;63:921-926
18. Powars DR, Chan LS, Schroeder WA. The variable expression of sickle cell disease is genetically determined. Semin Hematol. 1990;27:360-376
19. Wang W, Langston J, Steen G, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia: MRI, MRA, and neuropsychometric testing. Presented at the 22th Annual Meeting of the National Sickle Cell Disease Program, September 15-20, 1997, Washington, DC
20. Stockman JA, Nigro MA, Mishkin MM, et al. Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med. 1972;287:846-849
21. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326: 605-610
22. Adams RJ, McKie V, Hsu L, et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 1998;339:5-11
23. Pegelow CH, Adams RJ, McKie V, et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126:896-899
24. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan K. Bone marrow transplantation for sickle cell disease. N Engl I Med. 1996;335:369-376
25. Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effect on hemoglobin F production in patients with sickle cell anemia. Blood. 1992;79: 2556-2565
26. Ware RE, Steinberg MH, Kinney TR. Hydroxyurea. An alternative to transfusion therapy for stroke in sickle cell anemia. Am J Hematol. 1995;50:140-143